Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell, Cutaneous 3Lymphoma, T-Cell 3Lymphoma 2Immunoblastic Lymphadenopathy 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Mycosis Fungoides 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Prolymphocytic, T-Cell 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 9Biopsy 5Specimen Handling 4Prednisone 4Nivolumab 4Magnetic Resonance Spectroscopy 4fludarabine 3Vincristine 3Etoposide 3Doxorubicin 3Brentuximab Vedotin 3sodium-iodide symporter 2pembrolizumab 2fludarabine phosphate 2cemiplimab 2alectinib 2X-Rays 2Whole-Body Irradiation 2Stem Cell Transplantation 2Rituximab 2Positron-Emission Tomography 2Photons 2Mycophenolic Acid 2Immunoglobulin G 2Filgrastim 2Disulfides 2Cyclosporine 210-propargyl-10-deazaaminopterin 2treosulfan 1talimogene laherparepvec 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Anaplastic × romidepsin × 1 year × Clear all
NCT03278782 2026-01-09

Study of Pembrolizumab (MK-3475) in Combination With Romidepsin

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
39 enrolled
DermatologicLymphoid

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡